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Digital health innovations (DHIs) contribute to 
improving the health sector by revitalizing availability 
and continuity of care as well as mitigating rising 
costs. DHIs getting increasing support from health 
insurance companies and governmental institutions, 
but still struggle on their way to standard care in 
national healthcare systems. One of the central 
challenges is the multitude of diffusion barriers, which 
are either little known or difficult to handle in 
complexity and therefore pose a high risk for the 
translation into the healthcare practice. This paper 
steps into this discourse with a design-oriented 
research approach. A systematic literature review 
identified DHI barriers that are further evolved to a 
concept for assessing barrier resilience. On that basis, 
a framework to systematically administer diffusion 
barriers to DHI in Germany was developed. 
Innovators may use the proposed framework to assess 
the likelihood of a successful implementation and to 
ensure smooth scaling up process of their DHI. 
1. Introduction  
Digital technology and the  United Nations 
Sustainable Development Goals (SDGs) [1] are 
interwoven on a variety of levels. One example of this 
interplay is the third objective of the SDGs aiming at 
health-related action areas in which digital technology, 
in form of digital health, represents a significant element 
to achieve the formulated sustainability goals [2], [3]. 
Restraining this connection, however, digital healthcare 
solutions often face the scaling-up problem – a 
phenomenon that describes how digital health 
innovations (DHIs) are retained from finding their way 
into standard care. Solutions that have a demonstrable 
effect on care can frequently not unfold their benefits for 
the general public. Recently, regulatory measures such 
as the German Digital Healthcare Act show that political 
decisions support the digital transformation of the health 
sector and that digital health applications are 
acknowledged in care alongside medication [4]. 
Nevertheless, the basic problem remains: the complex 
and regulated healthcare environment imposes a large 
number of barriers to health innovations that are little 
known, especially to smaller innovators, and thus 
present a high risk to the successful development and 
exploitation of DHIs [5]. Small and medium-sized 
enterprises often struggle to identify such barriers and 
miss out on taking appropriate mitigation measures 
early on to ensure proper development and marketing of 
their solutions [6]. 
Therefore, we present an evaluation approach to 
support the early analysis and identification of possible 
deficits in targeting propagation barriers. Thus, we help 
to increase the accessibility of digital health applications 
and thereby the availability of healthcare for 
communities. Evaluation is used when informed 
decisions are to be made. The evaluation approach in 
this paper utilizes theoretical knowledge on propagation 
barriers of health innovations. Practitioners benefit from 
getting a concise outline of propagation-related 
strengths and weaknesses of their DHI in key figures. 
This can serve as a useful tool to develop sustainable 
digital health solutions that keep up with high 
expectations posed upon them and at the same time help 
researchers to further investigate the phenomenon of the 
scaling-up problem [7]. The design objective of this 
article is therefore linked to the question: 
 
What does an approach to assess the barrier 
resilience of Digital Health Innovations look like?  
 
A DHI in the context of this paper is the use of 
information and communication technology to deliver 
health or health-related services [3]. Nested in diffusion 
theory [8] and scaling-up of innovations [9], this paper 
builds on a body of preliminary work covering two 
domains: (1) diffusion barriers of DHIs and 
methodologies to reveal them as in analysing the lessons 
learned of DHI projects [10] and providing generic 
classifying taxonomies of DHI diffusion barriers [11]; 
and (2) a number of evaluation frameworks of DHIs. 





This paper complements recent initiatives to develop 
DHI evaluation frameworks [12], [13] by adding a 
categorization of existing evaluation approaches for 
health innovations and deriving an assessment 
framework from propagation barriers in healthcare. We 
add to the existing literature by newly accumulating 
knowledge from the two domains and providing an 
artifact as an applicable implementation of theory as 
design science [14]. The framework is exemplarily 
made-to-measure the German healthcare environment 
in order to show the applicability and utility of the 
approach in a concrete healthcare market. Generally, 
Germany can also serve as a representative example 
among OECD states with Social Health Insurance, i.e., 
societal actors decide on regulations and financing while 
services are largely provided by private for-profit actors 
[15]. The final assessment, however, needs to be tailored 
to the specific national context.  
Starting with researching propagation barriers 
focusing on DHIs in Germany, the identified corpus of 
contributions centered around these barriers is 
examined. Next, we present our methodology (Section 
2) and provide an overview of existing evaluation 
approaches (Section 3). Based on that, an assessment 
approach tailored to the German healthcare environment 
is designed (Section 4). The resulting framework is 
tested using an exemplary project in the German 
healthcare market with a phenotypical character for 
DHIs (Section 5). The paper closes with a discussion of 
the results (Section 6) and concluding remarks as well 
as an outlook on further research (Section 7). 
2. Methodology 
The methodological approach is based on the 
Design Science Research (DSR) principles [16] and 
aligned with a DSR process (DSRP) model [14]. The 
relevance and problem identification (DSRP Phase 1) as 
well as the design objective (DSRP Phase 2) was 
elaborated in Section 1. The artifact is constructed in 
multiple steps (DSRP Phase 3) as follows: In order to 
comply with DSR-guidelines and to ground the research 
on rigorous practices, a systematic literature search was 
carried out to accumulate literature broaching the issue 
of diffusion barriers in healthcare [17]. Based on this, 
the research results were analyzed using inductive 
category formation by Mayring to identify propagation 
barriers of DHIs in general and specific barriers in 
Germany [18]. Next, existing approaches to evaluating 
digital health solutions were identified in a second 
literature search. To map the ground covered by 
preliminary research, a taxonomy was created helping 
to categorize existing DHI assessment approaches [19]. 
The categorization revealed an existing artifact that is 
iterated to fit the needs of an evaluation tool synthesized 
for the German environment [20]. Finally, this paper’s 
framework is applied (DSRP Phase 4) and evaluated 
(DSRP Phase 5) using a practical example. 
Identification of propagation barriers. In order to 
identify existing literature on propagation barriers in the 
German healthcare system, scientific databases were 
searched for relevant contributions on August 4, 2018 
[17], [21]. The search term consisted of three elements 
to which synonyms in German and English were added: 
(1) barriers (obstacles, hurdles, resistance, etc.), (2) 
propagation mechanisms (scaling-up, translation, 
diffusion, etc.) and (3) digital health innovations 
(eHealth, telemedicine, telehealth, etc.). The search 
queries were applied to the databases EBSCOhost, 
ScienceDirect, IEEE Xplore, SpringerLink, PubMed 
and AIS Electronic Library (+368). Duplicates, non-
English and non-German contributions as well as 
contribution types such as dictionary entries and 
announcements were removed from the corpus (-158). 
From the remaining publications, relevant contributions 
were selected on the basis of an inclusion criterion, 
which was checked against the respective abstract [22], 
[23]. The inclusion question was: Are barriers to the 
spread of digital solutions in the healthcare system or 
the basic parameters for digital innovations in the 
German healthcare system being investigated? (-191). 
In a final acquisition step, this selection was subjected 
to a backward reference search (+3). One publication 
was not accessible (-1), creating an overall literature 
corpus of 21 publications.  
Inductive category formation is used to map the 
material on propagation barriers distortion-free [18]. 
For the first step of the category formation, the aim of 
the process has to be defined. The aim is to extract the 
barriers to propagation of DHIs in the German 
healthcare system from the body of literature, consisting 
of 21 publications. Next, a selection criterion will be 
defined to determine which passages of text are used to 
induce the formation of categories. If sections are found 
that can be assigned to the selection criterion, the first 
category is formulated as close as possible to the text 
formulation and confirm to the level of abstraction. 
Further categories are formed from the following text 
passages that fit into the selection if they can not be 
subsumed under existing categories. The categories are 
revised in an intermediate step before the material is 
completely worked through and the categorization can 
be interpreted. The result is depicted in Table.1. 
 
Analysis of existing assessment approaches. A 
second systematic literature search was carried out to 
record the state of research on evaluating the spread of 
digital health solutions on November 12, 2018 [17], 
[21]. Into this search, both, scientific contributions 
(+225) and grey literature (+20) were included. The 
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search queries combined (1) types of digital health 
innovations (eHealth, telemedicine, etc.), (2) artifact 
types (framework, model, etc.) and (3) an element 
related to evaluation (quality management, evaluation, 
etc.). The search was carried out in the scientific 
databases PubMed, ScienceDirect, EBSCOhost and 
SpringerLink, as well as for grey literature with the 
search engine Google. Contributions were selected 
qualitatively for closer examination (-218). A forward 
reference search revealed additional relevant literature 
(+4). The second literature corpus, consisting of 31 
publications, was categorized using a taxonomy to get 
an overview of the scope of preliminary work at 
transparent standards [19].  
 
Synthesis of the DHI assessment approach. 
Investigating existing evaluation approaches of digital 
health innovations, revealed that no distinct tool helping 
to address propagation barriers in the German healthcare 
system exists. This paper sets out to fill the lack of a 
Germany-centered solution to help practitioners 
dispatch propagation issues of their health innovations. 
Therefore, an evaluation sheet will be developed to 
assess how effectively barriers to the spread of digital 
health applications were dealt with. Since the draft to be 
designed contains an evaluation aspect, the Roadmap 
for Planning an Evaluation Concept for the Area of E-
Health is used for the development of the artifact [24]. 
Complying with DSR-guidelines, the approach is finally 
demonstrated and evaluated [16]. 
3. Status of research 
Research on the propagation barriers as well as 
evaluation approaches for DHIs already exist. This 
section presents an overview of these publications and 
derives barriers under consideration in this article from 
the literature base. Afterward, existing assessment 
frameworks are scrutinized according to their ability to 
suit the requirements imposed by the environment the 
German healthcare system operates in. 
 
Identification of barriers to the spread of digital 
health innovations in Germany. Based on the first 
literature search, propagation barriers for innovations 
are identified through inductive category formation. 
Since the formed categories shall reflect propagation 
barriers, the selection criterion is: Propagation barrier 
for digital health innovations that are unique to the 
healthcare context and can be transferred to the 
German context. Categories that specifically refer to a 
non-German context are not formed (e.g. barriers from 
guidelines in sub-Saharan Africa). Thus, 33 categories 
were identified. In summary, six super-categories were 
formed (see also Table.1 for details):  
(1) Reimbursement and Financing relates to 
barriers associated with monetary and budgeting issues 
as well as reimbursement of digital solutions in the 
public healthcare system [11], [25]–[28]. (2) 
Regulations and Guidelines sum up hurdles posed by 
statutory compulsions that have to be complied with 
[11], [25], [26], [29]. (3) Technical Barriers originate in 
technological restrictions or difficulties [11], [25]–[27], 
while (4) Medical Proof of Effectiveness confirms the 
medical properties of an innovation in healthcare [11], 
[26]–[28]. (5) Economic Proof of Efficiency 
encompasses issues around validating the return of 
investment of an innovation. [28] (6) User Acceptance 
focuses on social and organizational factors influencing 
the propagation of DHIs [11], [25]–[27], [30]–[32]. 
 
Table.1 Categories of propagation barriers  
Super-categories Categories and selected references  
(1) Reimbursement and 
Financing 
Remuneration conditions cross-sectoral; Remuneration conditions in the stationary sector; 
Reimbursement in the outpatient sector; Non-remuneration of cost savings; Infrastructure 
costs; High initial costs; Low willingness to pay on the second healthcare market [19]-[23] 
(2) Regulations and Guidelines 
Health market approval conditions; Legal data protection regulations; Lack of standardised 
regulations: Liability risks; Ban on remote treatment [19]-[21], [24]  
(3) Technical Barriers 
Technical maintenance; Infrastructural barriers; Lack of security/reliability of medical data; 
Lack of technical interoperability/compatibility [19]-[22] 
(4) Proof of Effectiveness 
Deficit in studies; Missing certification method; Lack of evidence of efficacy; Lack of 
evaluation methodology [20]-[23] 
(5) Proof of Efficiency Lack of efficiency evidence; Duration of efficiency assessment [23] 
(6) User Acceptance 
Knowledge and competence-related barriers; Insufficient relative advantage; Necessary 
process changes; Resistance of the practitioner to changes in established practices; Questions 
of trust towards the provider; Unsuitable organizational structure of the adopters; 
Stigmatization of the patient; Reading/spelling deficit of the patient; Conservative attitude of 
physicians towards innovations; Lack of technical affinity or knowledge among physicians 
and patients; Fear of job loss on the part of the physician [19]-[22],[25]-[27] 
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Mapping of existing DHI assessment 
approaches. Subsequently, a taxonomy was created to 
categorize the preliminary work containing evaluation 
approaches of DHIs. The aim is to find out to what 
extent the mentioned barriers to propagation have 
already been considered in evaluations of other authors. 
The taxonomy was created in seven iteration steps, 
resulting in seven taxonomy dimensions [19]. 
The first iteration distinguishes whether a 
contribution is applicable to a practical problem 
(Concrete), or whether it is a draft, a requirements 
analysis, a naming of critical factors, a recommendation 
or a plea for evaluation (Abstract). The second iteration 
differentiates between objects under consideration 
along the span of DHIs, as described in Otto et al. 2018. 
Iteration number three distinguishes between the 
intended geographical sphere of influence of the 
contribution (Global/No Specification, Developed Non-
EU Country, Developing Country, EU, Non-German 
EU-country and Germany). The next iteration creates a 
dimension to document the extent to which a 
contribution addresses the propagation barriers earlier 
identified with inductive category formation. The fifth 
iteration differentiates whether a contribution considers 
the overall quality of an intervention concept (Quality of 
the Intervention Concept), whether it supports an 
increased spread of the intervention (Diffusion Related), 
whether it focuses on the condition of an innovation 
(State Evaluation) or the successful implementation of 
the intervention (Successful Implementation). Iteration 
number six distinguishes whether an evaluation 
approach makes a summary statement (Summative), 
whether it is conducted in parallel to an implementation 
of the measure and influences it (Formative), or whether 
a contribution explores evaluation abstractly and no 
statement can be assigned to the mode (e.g. a plea for 
alignment of evaluation with certain standards, Too 
Abstract for a Mode) [18]. The last iteration categorizes 
contributions proposing or delivering a quantitative 
(Ordinal) or a qualitative (Nominal) evaluation result. A 
publication under consideration may be too vague to 
make a statement about the evaluation result (Too 
Abstract for a Result). The resulting taxonomy 
displaying the identified dimensions and characteristics 
is depicted in Table.2. 
The taxonomy was applied to describe and 
categorize 31 identified assessment approaches in the 
second literature search (Section 2 Analysis of existing 
assessment approaches). The results reveal that so far, 
no contribution has been made that allows assessing 
which propagation barriers were being addressed by a 
DHI in the context of the German healthcare system.1 
                                               
1 The complete list of analyzed assessment approaches and results of 
applied taxonomy will be provided as an additional data source.  
That implies that only little guidance exists for 
practitioners in this field to support development efforts 
and make a DHI fit for seamless spread. Therefore, an 
adequate evaluation approach is developed in the next 
section.  
4. Synthesizing the evaluation approach  
An evaluation approach helps stakeholders to 
assess the extent to which potential for scaling-up an 
innovation is being exploited and supports with 
recommending measures for successful market 
diffusion. This goal is worked towards in this section by 
synthesizing an evaluation approach that offers the 
opportunity to gather propagation barrier-related 
information about DHIs systematically and produce 
quantitative results indicating the innovation’s barrier 
resilience [24]. The approach is designed in accordance 
with the evaluation standards Usefulness, Feasibility, 
Fairness and Accuracy [33].  
For the artifact design, an existing scoring system 
will be altered and refined as intended in a DSR-artifact 
iteration [16]. This scoring system originally is the 
backbone of the MAPS-Tool (mHealth Assessment and 
Planning for Scale, WHO 2015), a framework 
examining mHealth-solutions focussing on their 
suitability for scaling-up along defined categories (Axis 
of Scale). Each category contains several globally 
applicable questions on the measures taken to achieve 
scaling goals. The quantification system that was 
employed is a four-stage point system. 
Each category is rated depending on the response 
option picked by the surveyor: No (0 points), In 
Progress (1 point), Executed (2 points); Documented (3 
points) or Not Applicable (3 points). Non-fulfillment 
(No) expresses the previous disregard of the barrier 
aspect and is thus interpreted negatively. From there the 
rating increases leading to the documented 
confrontation with barriers (Documented), relating to 
testified efforts being made, and thus scores highest due 
to its traceability. If questions are not applicable, they 
are assessed positively to avoid influencing the overall 
picture unfavorably. Since five criteria are asked for 
each barrier, each of which is evaluated with up to three 
points, the evaluation sheet is based on a 15-point  
system. The modification of the MAPS-Tool concerns 
the frame of reference of the evaluation, which is 
alienated from generic global criteria and finds its 
unique feature compared to other approaches through 
the special reference to German propagation barriers. 
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Furthermore, it is made applicable for every kind of 
DHI, including mHealth, telemedicine, telemonitoring, 
eHealth and alike [10]. Thus, a thorough analysis of the 
German healthcare system was conducted along the 
barriers for DHIs to concretize the six super-categories 
in appropriate assessment items. The adaptation of the 
following assessment approach to other national 
specifications requires an appropriate adjustment of this 
step of analysis and design. 
 
(1) Reimbursement and Financing was covered 
with an analysis of possibilities for reimbursement in the 
ambulant and stationery sector as well as the 
intersectoral reimbursement.  
(2) Regulations and Guidelines incorporate 
findings related to the E-Health-Law (SGB V), like the 
registration of DHIs in the a public online 
interoperability register (gematik’s vesta information 
portal [34]), as well as data security regulations 
(DSGVO/GDPR), laws regarding medical products 
including Conformité Européenne (CE) certification, 
and IT security regulations with policies for critical 
infrastructure (KRITIS).  
(3) Technical Barriers were considered including 
technical (HL7, DICOM, xDT) and semantic 
communication standards (OPS, ICD, SNOMED CT, 
LOINC) as well as technical security requirements for 
medical devices (93/42/EWG) and data security 
considerations (§ 64 BDSG). Additionally, transmission 
technology and special user needs have to be 
considered.  
(4) Proof of Medical Effectiveness contains 
measures assuring compliance with the principle of 
evidence-based medicine in the public healthcare 
system, the role of clinical trials (93/42/EWG) and 
peculiarities of health technology assessments (HTAs).  
                                               
2 Information about mySugr has been collected from company 
websites. Details may differ due to national specifications. 
(5) Economic Proof of Efficiency encompasses 
actions towards the efficiency command (§ 12 SGB V) 
in the German public healthcare system and variations 
of health-economic analysis as well as cost types to 
prove equal or better care provision for lower costs.  
Finally, (6) User Acceptance utilized the 
Technology Acceptance Model to analyze patient and 
practitioner needs [35]. The resulting assessment form 
can be seen in Table.3. The scores for the aspects in 
question can be documented in the left column.  
5. Demonstration 
The newly developed artifact will be demonstrated 
on a phenotypical digital health solution with a user base 
in Germany. The case study is based on the application 
mySugr: your intelligent diabetes diary. Among the 
functions of mySugr2 are collecting and graphically 
processing information on diabetes (e.g. blood sugar, 
meals, medication, physical activities) in the form of a 
diary to optimize therapy outcomes and mitigate the 
course of the disease [36].  
 
1) Reimbursement and Financing. mySugr is a 
medical device and therefore belongs to the first health 
market [37]. The app is available in a free basic version 
and can be extended in its functions by using a version 
with costs. Since April 2018, some private health 
insurance companies reimbursed the costs for using the 
application [38]; from July 2018, this was also offered 
by a selection of public health insurance companies. 
Various financing models of the public and private 
sectors were considered, implemented and documented. 
Patient-financed, as well as health insurance-financed 
models, are available. Score: 15 
Table.2 Taxonomy of existing evaluation approaches for digital health innovations 
Dimensions Characteristics 
Level of 
Abstraction Concrete Abstract 
Object of 





























Quality of the 
Intervention Concept Diffusion Related Status Evaluation 
Successful 
Implementation 
Mode Summative Formative Too Abstract for a Mode 
Scale of Results Ordinal Nominal Too Abstract for a Result 
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2) Regulations and Guidelines. The application is 
designed as a tracker and diary of diabetes data and does 
not include remote treatment functions [39]. mySugr 
ensures compliance with various data protection 
guidelines in the data protection declaration [40]. In 
addition, the app is approved as a Class I medical device 
(one module as Class II). The application is not critical 
infrastructure so that special requirements for KRITIS 
do not apply. Deductions apply because mySugr is not 
registered in the vesta Informationsportal. Score: 12  
 
3) Technical Barriers. The technical design of the 
diabetes tracker for the protection of personal data is 
reassured in company statements [41], with reference to 
the use of the Amazon Web Services cloud infrastructure 
and its certificates and compliance with standards and 
guidelines. The security design is again proven by the 
CE conformity of mySugr. The application is 
interoperable with various blood glucose monitoring 
devices [39]. The transmission of larger amounts of data 
does not result from the application’s use cases so that 
latency times do not have to be considered. The user 
ratings confirm that the app mostly fulfills user-specific 
requirements [43]. Number of points: 13 
 
4) Medical Proof of Efficacy. The medical 
efficacy of mySugr has been demonstrated and 
published [44], [45]. Thereby, the present state of 
studies was improved, and the reimbursement model 
was backed-up with clinical data. Testing times and 
mechanisms did not pose a lasting threat to the existence 
of the project. Score: 15 
 
5) Economic Proof of Efficiency. Support from 
investors for the development team indicates proved 
efficiency. Financing rounds between 2014 and 2015 
ended with a monetary backing of several million euros 
[46] and culminated in the takeover by Roche in 2017 
[47]. Score: 15 
 
6) User Acceptance. The application is specifically 
designed to meet the documentation needs of diabetics. 
Despite the very good ratings on Google Play, there are 
hints from users in the comments about the app's 
inadequacies [43]. The mySugr website offers training 
courses on how to use the app [48]. Stigmatization of 
users is prevented with a humorous character of 
application and the creation of a sense of community in 
the user base through blog entries and newsletters. 
Support is available on a variety of channels [49]. 
Studies were conducted to measure user satisfaction, in 
which the application was rated positively [50]. Score: 
13 
 
Figure 1. Visualization scoring “mySugr” 
 
The demonstration showed that the presented 
approach to propagation barrier assessment is applicable 
to a popular DHI that is used on the German market. It 
helps to analyze which hurdles imposed on DHIs by the 
German healthcare system were addressed by mySugr-
developers and which would still need some attention in 
order to speed up the spread of the application and reach 
a higher volume of users. 
6. Discussion  
Based on the results of the former sections, the 
designed assessment approach is evaluated with respect 
to the standards of the German association for 
evaluation [33]. Usefulness. The result of the 
assessment of mySugr coincides with the actual 
successful propagation development of the application. 
The next step would be to examine low scored areas and 
take measures to address under-considered barriers. 
Whether those measures lead to practice-relevant 
changes for the application could not be clarified in the 
demonstration. However, the evaluation remains a 
visible confirmation for outsiders reflecting the strong 
positioning of mySugr, which presents a benefit. 
Feasibility. The feasibility of the assessment largely 
depends on the robustness of the information base for 
the solution under consideration. In the case of mySugr, 
the company’s tendency to openly communicate with its 
userbase contributed to a highly feasible assessment. 
However, with the knowledge of a company insider, 
statements could have been made more accurately. 
Fairness. Measures must be taken to ensure that all 
information necessary for an assessment is available to 
all stakeholders at all times, i.e. that assessments of 
solutions take place under the same (fair) conditions for 
third parties. One possibility could be to access 
standardized data for assessment in the vesta 
Informationsportal, although it is often provided 
insufficiently. In order to preserve the feasibility of an 
evaluation to cover the full range of DHIs, fairly generic 








compromised the accuracy of the evaluation of an 
mHealth application. Accuracy. The assessment of 
mySugr resulted in an overall positive score indicating 
that most of the propagation barriers were addressed and 
dealt with, which is reflected in the successful market 
dissemination of the app. However, compromises had to 
be made regarding the assessment parameters (No, In 
Progress, Executed, Documented/Not Applicable). 
They are not linked to the quality of a measure taken and 
its sustainable effectiveness, which affects the effective 
barrier resilience of an application. Therefore, more 
resilient metrics for the assessment of barrier aspects 
have to be introduced. 
 
This article contributes to diffusion and 
adoption research in healthcare. It offers insides into 
the aspects of healthcare-specific diffusion barriers by 
integrating former research in the area and applying a 
distinct focus on the German environment. The resulting 
categorization offered a frame for investigating the 
German healthcare system under more narrow thematic 
limitations. Additionally, a review of preliminary 
research on healthcare innovation barriers was provided. 
These two preparatory steps lead to the design of an 
easy-to-use approach to assess the readiness of an 
innovation to successfully spread. Usefulness and 
functionality of DHI play only a secondary role in this 
approach. Sustainable value is rather added by shifting 
from functionality-focused thinking towards 
dissemination-centered considerations. Summarizing 
this paper’s scientific relevance: it enriches existent 
knowledge about DHI diffusion into healthcare markets 
by a formative assessment method that allows the 
determination of how a DHI may take the hurdles of 
concrete diffusion barriers. In a broader sense, the 
presented measures imply design principles of DHI.  
 
The presented artifact is aligned with the EU 
interoperability framework. The proposed evaluation 
approach supports innovators and development teams 
struggling with the complexity of DHI diffusion into 
day-to-day healthcare. As interoperability is considered 
highly relevant to ensure DHI diffusion success, 
research and consensus processes of eHealth Network (a 
task network of the European Commission) led to the 
Refined European Interoperability Framework (ReEIF) 
in 2015 as a general definition for eHealth 
interoperability. The contribution of this paper is 
aligned with this consensus as categories and super-
categories address the six interoperability levels of 
ReEIF (Legal and regulatory; Policy; Care Process; 
Information; Applications; IT-Infrastructure) [51]. 
Thus, the proposed assessment approach breaks down 
the complexity of DHI diffusion while offering an aid 
kit for struggling innovators. 
The presented artifact is also subject to 
limitations. One limitation results from the 
methodology of the literature-based research approach 
deriving barriers with inductive category formation. 
This practice results in categories formed on the one 
hand regardless of contemporary significance, on the 
other hand relying on the assumption that relevant 
barriers were already being discovered in preliminary 
research. Thus, it can not be guaranteed that the barriers 
found have practical relevance, which requires research 
in the field and can be worked on by conducting expert 
interviews. Additionally, the categories that were 
formed and represent propagation barriers exist in de 
facto interdependence but were considered as being 
separate in this paper. That could lead to false 
compartmentalization of the healthcare system during 
the attempt to create the assessment approach. Another 
basic potentially misleading assumption was created 
around the unified understanding of the terminology 
summed up in the term digital health during the research 
on existing evaluation frameworks. Thus, subsequent 
categorizations of named approaches might have 
suffered from ambiguity. Furthermore, the evaluation 
revealed that the quality of the information fed into the 
assessment model is pivotal for the assessment outcome. 
Hence the reliability of the information used in the 
artifact application has to be ensured. Moreover, proof 
is required that the assessment approach followed by the 
scoring system does indeed support hands-on decision 
making. This is especially true, since the descriptions of 
the healthcare environment the assessment is based on, 
was only briefly broached and is currently not to the 
innovator’s disposal in case a category scored low. 
Finally, the frame in which this approach to DHI 
assessment is tailored to is currently limited to the 
German healthcare context. That limitation was 
necessary to create a usefully specific, manageable 
framework in the first place, seeing the German 
healthcare system as fairly homogeneous. Since that 
focus was set in such an early stage of research, the 
migration of the assessment framework to another 
region might require fundamental content changes early 
on. However, the methodology would be just as 
applicable and an expansion to other OECD member 
states with Social Health Insurance [15] might require 
slight modifications only. 
7. Conclusion  
This paper discussed a central issue of digital health 
innovations – even highly optimized DHIs with strong 
problem-solving potential do not necessarily scale-up in 
the intended environment. A crucial factor for that are 
system-imposed barriers that have to be taken into 
consideration to introduce innovations to end-users and 
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unfold expected benefits for care provision. To tackle 
this issue, a first draft of an evaluation approach was 
developed to determine the resilience of DHIs to 
propagation barriers in the German healthcare system. 
Apart from improving the approach by additional 
research on the limitations, the assessment can be 
extended to a stakeholder perspective by linking 
propagation barriers to corresponding interest groups in 
the healthcare system. These interest groups often have 
contradicting goals and different levels of influence on 
DHI-diffusion success. Thus, the extension would 
benefit the overall approach by weighting barriers 
stakeholder-sensitively which adds more accuracy to the 
scoring. In practice, the presented approach could be 
implemented as an evaluation tool on a platform for 
digital health solutions using the already available 
ordinal scoring or adding a nominal dimension, 
describing addressable barrier aspects based on the 
assessment in greater detail. Such services could either 
provide guidance to developers working on DHIs or 
assist with investment decisions into promising 
innovations. Thus, the approach introduced in this paper 
can contribute to using scarce resources in healthcare 
more sustainably. 
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